Compare ALEC & CPSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALEC | CPSS |
|---|---|---|
| Founded | 2013 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.4M | 210.7M |
| IPO Year | 2019 | 2010 |
| Metric | ALEC | CPSS |
|---|---|---|
| Price | $2.22 | $9.66 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 535.8K | 30.4K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.27 |
| EPS | N/A | ★ 0.24 |
| Revenue | $21,045,000.00 | ★ $434,470,000.00 |
| Revenue This Year | $2.03 | $147.09 |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | $39.88 |
| Revenue Growth | N/A | ★ 10.41 |
| 52 Week Low | $1.09 | $6.67 |
| 52 Week High | $3.40 | $10.49 |
| Indicator | ALEC | CPSS |
|---|---|---|
| Relative Strength Index (RSI) | 46.99 | 53.43 |
| Support Level | $1.91 | $9.40 |
| Resistance Level | $2.64 | $10.41 |
| Average True Range (ATR) | 0.16 | 0.37 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 36.04 | 23.85 |
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.